Program Committee

Say “hello” to the ISPOR 2025 Program Committee!  ISPOR is excited to work with an amazing group of talented and passionate members dedicated to curating a robust slate of sessions and building an impactful program. It’s through their collaboration with ISPOR that we can deliver a meaningful experience to our attendees. 

Members

Tamás Ágh, MD, MSc, PhD
Research Associate Professor, Center for Health Technology Assessment and Pharmacoeconomic Research, University of Pécs & Syreon Research Institute, Hungary

Suliman Alghnam, PhD
Executive Director of Surveillance, Saudi Public Health Authority, Saudi Arabia

Patricia Aluko, BPharm, MSc
Global Health Outcomes Lead, Reckitt Benckiser, United Kingdom

Anita Brogan, MSc, PhD
Vice President, Decision Analytic Modeling, Health Economics, RTI Health Solutions, USA

Randa Eldessouki, MS, MD
Professor, Fayoum University, Egypt

Vijay S. Gc, MPH, PhD
Senior Lecturer in Health Economics, School of Human and Health Sciences, University of Huddersfield, United Kingdom

Salah Ghabri, MSc, PhD
Senior Scientific Referent in Health Economics, Department of Medical Evaluation, French National Authority for Health, France

Boris Gorsh, PharmD
Senior Director, Global Oncology HEOR and RWE, Daiichi-Sankyo Inc., USA

Michael Grabner, PhD
Principal Scientist, Carelon Research, USA

Jason R. Guertin, PhD
Associate Professor, Faculty of Medicine, Université Laval, Canada

Sebastian Heidenreich, BSc, MSc, PhD
Executive Director, Patient-Centred Research, Evidera, United Kingdom

William L. Herring, PhD
Executive Director, Health Economics, RTI Health Solutions, USA

Stacie Hudgens, MA
Chief Scientific & Strategy Officer, Clinical Outcomes Solutions LLC, USA

Manthan D. Janodia, MPH, PhD
Professor and Head, Department of Pharmaceutical Regulatory Affairs and Management, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, India

Min-Hua Jen, PhD
Senior Director, Eli Lilly, United Kingdom

David D. Kim, PhD
Assistant Professor, Department of Medicine and Public Health Sciences, University of Chicago, USA

Yifei Liu, BS, MS, PhD
Associate Professor, Division of Pharmacy Practice and Administration, The University of Missouri-Kansas City School of Pharmacy, USA

Siu Hing Lo, MA, MSc, PhD
Director, Acaster Lloyd, United Kingdom

Graciela Luraschi, MS
Professor, J. F. Kennedy University, Argentina

Olena Mandrik, MSc, PharmD, PhD
Senior Research Fellow, The University of Sheffield, United Kingdom

Stephanie Manson, PhD
Clinical Connections, USA

Homero Monsanto, BS, MS, PhD
Professor, International Public Health Program, Ponce Health Sciences University, USA

Marjorie Morrison, MHA
Director, Policy & Advocacy, Lymphoma Coalition, Canada

Tarlan Namvar, MSc, PharmD
Senior Analyst, Health Economics and Reimbursement, Abbott, USA

Soumana Nasser, PharmD
Associate Professor, Pharmacy Practice Department, Lebanese American University, Lebanon

Bertalan Nemeth, PhD
Principal Health Economist, Syreon Research Institute, Hungary

Laura Panattoni, PhD
Director, Precision AQ, USA

Jessica Roydhouse, PhD
Senior Research Fellow, Menzies Institute for Medical Research, University of Tasmania, Australia

Oriol Solà-Morales, MSc, PhD, MD
Chair & CEO, Fundació HiTT, Spain

Priyamvada Tewari, MS, PhD
Director, Commercial Life Sciences and Med Tech, Mathematica Policy Research, USA

Kimberly Westrich, MA
Chief Strategy Officer, National Pharmaceutical Council, USA

Xiao Xu, PhD
Herbert and Florence Irving Associate Professor, Department of Obstetrics and Gynecology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, USA